中国医药导报
中国医药期刊欢迎您 今天是   2025年4月4日星期五
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报  2023, Vol. 20 Issue (35): 14-18    DOI: 10.20047/j.issn1673-7210.2023.35.03
  论著 本期目录 | 过刊浏览 | 高级检索 |
CTA结合CTP对单侧大脑中动脉供血区脑梗死患者治疗及康复效果的预测价值
常冬梅1 李志伟2▲
1.江苏省苏州市中西医结合医院影像科,江苏苏州 215101;
2.苏州大学附属第二医院影像科,江苏苏州 215101
Predictive value of CTA combined with CTP in the treatment and rehabilitation of patients with unilateral middle cerebral artery infarction
CHANG Dongmei1 LI Zhiwei2▲
1.Department of Imaging, Suzhou Integrated Traditional and Western Medicine Hospital, Jiangsu Province, Suzhou 215101, China;
2.Department of Imaging, the Second Affiliated Hospital of Suzhou University, Jiangsu Province, Suzhou 215101, China
全文: PDF (971 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨CT血管成像(CTA)结合CT灌注成像(CTP)对单侧大脑中动脉供血区脑梗死患者治疗及康复效果的预测价值。 方法 选取2020年1月至2022年10月在江苏省苏州市中西医结合医院治疗的单侧大脑中动脉供血区脑梗死患者89例,所有患者均给予常规治疗,随访至治疗后90 d,分析比较治疗有效(65例)和无效(24例);预后良好(57例)和不良(32例)患者临床资料、CTA和CTP参数差异。 结果 治疗有效和无效患者侧支循环、相对脑容量(rCBV)比较,差异有统计学意义(P<0.05)。侧支循环(不良=1,良好=0)、rCBV及二者联合预测治疗无效的受试者操作特征(ROC)曲线下面积分别为0.780、0.724和0.745(P<0.05)。预后良好和不良患者侧支循环、rCBV、相对平均通过时间比较,差异有统计学意义(P<0.05)。侧支循环(不良=1,良好=0)、rCBV及联合预测预后不良的ROC曲线下面积分别为0.836、0.767和0.778(P<0.05);相对平均通过时间预测预后不良的ROC曲线下面积为0.620(P>0.05)。 结论 CTA结合CTP对单侧大脑中动脉供血区脑梗死患者治疗效果及预后方面有一定的预测价值,值得进一步研究。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
常冬梅1 李志伟2▲
关键词 CT血管成像CT灌注成像单侧大脑中动脉治疗效果预后预测价值    
Abstract:Objective To investigate the predictive value of CT angiography (CTA) combined with CT perfusion imaging (CTP) in the treatment and rehabilitation of patients with unilateral middle cerebral artery infarction. Methods A total of 89 patients with unilateral middle cerebral artery infarction who were treated in Suzhou Integrated Traditional and Western Medicine Hospital from January 2020 to October 2022 were selected, all patients were given routine treatment, follow-up to 90 days after treatment, the clinical data, CTA and CTP parameters of patients with effective (65 cases) and ineffective (24 cases) treatment, good prognosis (57 cases) and bad prognosis (32 cases) were analyzed and compared. Results There were significant differences in collateral circulation and relative cerebral volume (rCBV) between effective and ineffective patients (P<0.05). The area under receiver operator characteristic(ROC) curves for collateral circulation (poor =1, good =0), rCBV and combined prediction of treatment failure were 0.780, 0.724, and 0.745, respectively (P<0.05). There were significant differences in collateral circulation, rCBV, and relative mean transmit time between good and bad prognosis patients (P<0.05). The area under ROC curve of collateral circulation, rCBV and combined prediction of poor prognosis were 0.836, 0.767 and 0.778, respectively (P<0.05). The area under ROC curve of relative mean transmit time for predicting poor prognosis was 0.620 (P>0.05). Conclusion CTA combined with CTP has a certain predictive value in the treatment effect and prognosis of patients with unilateral middle cerebral artery infarction, which is worth further study.
Key wordsCT angiography    CT perfusion imaging    Unilateral middle cerebral artery    Therapeutic effect    Prognosis    Predictive value
    
基金资助:国家自然科学基金资助项目(82170831)。
通讯作者: ▲通讯作者   
引用本文:   
常冬梅1 李志伟2▲. CTA结合CTP对单侧大脑中动脉供血区脑梗死患者治疗及康复效果的预测价值[J]. 中国医药导报, 2023, 20(35): 14-18.
CHANG Dongmei1 LI Zhiwei2▲. Predictive value of CTA combined with CTP in the treatment and rehabilitation of patients with unilateral middle cerebral artery infarction. 中国医药导报, 2023, 20(35): 14-18.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/10.20047/j.issn1673-7210.2023.35.03     或     https://www.yiyaodaobao.com.cn/CN/Y2023/V20/I35/14

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司